130 / 140
Guía OncoSur de sarcomas de partes blandas
130
>
144. Stacchiotti S, Grosso F, Negri T, et al. Tumor response to sunitinib malate observed in clear-cell sarcoma. Ann
Oncol 2010;21:1130-1.
145. Tazzari M, Palassini E, Vergani B, et al. Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell
sarcoma patient treated with sunitinib: a case report. BMC Cancer 2015;15:58. DOI 10.1186/s12885-015-
1044-0.
146. Mir O, Boudou-Rouquette P, Larousserie F, et al. Objective response to sorafenib in advanced clear-cell sarco-
ma. Ann Oncol 2012;23(3):807-9.
Tumor desmoplásico de células redondas
147. Lal D, Su W, Wolden S, et al. Results of multimodal treatment for desmoplastic small round cell tumors.
J Pediatr Surg 2005;40:251-5.
148. Mrabti H, Kaikani W, Ahbeddou N, et al. Metastatic Desmoplastic Small Round Cell Tumor Controlled by an
Anthracycline-Based Regimen: Review of the Role of Chemotherapy. J Gastrointest Canc 2012;43:103-9.
149. Rosoff PM, Bayliff S. Successful clinical response to irinotecan in desmoplastic round blue cell tumor. Med
Pediatr Oncol 1999;33:500-3.
150. Bisogno G, Riccardi R, Ruggiero A, et al. Phase II study of a protracted irinotecan schedule in children with
refractory or recurrent soft tissue sarcoma. Cancer 2006;106:703-7.
151. Bisogno G, Riccardi R, Scagnellato A, et al. No effect of irinotecan in patients with resistant desmoplastic
small round cell tumor. Pediatr Blood Cancer 2010;54(1):182-3.
152. Anderson PM, Pearson M. Novel therapeutic approaches in pediatric and young adult sarcomas. Curr Oncol
Rep 2006;8:310-5.
153. Frezza A, Whelan J, Dileo P. Trabectedin for desmoplastic small round cell tumours: a possible treatment op-
tion? Clin Sarcoma Res 2014;4:3.
154. López-González A, Cantos B, Tejerina E, et al. Activity of trabectedin in desmoplastic small round cell tumor.
Med Oncol 2011;28:S644-S646.
155. Verret B, Honore C, Dumont S, et al. Trabectedin in advanced desmoplastic round cell tumors: a retrospective
single-center series. Anticancer Drugs 2017;28(1):116-9.
156. Brunetti A, Delcuratolo S, Lorusso V, et al. Third-line trabectedin for a metastatic desmoplastic small round
cell tumour treated with multimodal therapy. Anticancer Res 2014;34:3683-8.
157. George S, Merriam P, Maki RG, et al. Multicenter phase II trial of sunitinib in the treatment of nongastrointes-
tinal stromal tumor sarcomas. J Clin Oncol 2009;27:3154-60.
158. Italiano A, Kind M, Cioffi A, et al. Clinical activity of sunitinib in patients with advanced desmoplastic round
cell tumor: a case series. Target Oncol 2013;8:211-3.
159. Ikeue T, Ohi I, Noguchi S, et al. Desmoplastic Small Round Cell Tumor of the Pleura Successfully Treated with
a Lower Dose of Pazopanib. Intern Med 2016;55:2463-7.
Condrosarcoma mixoide extraesquelético
160. Patel SR, Burgess MA, Papadopoulos NE, et al. Extraskeletal myxoid chondrosarcoma. Long-term experience
with chemotherapy. Am J Clin Oncol 1995;18:161-3.
161. Drilon AD, Popat S, Bhuchar G, et al. Extraskeletal myxoid chondrosarcoma: a retrospective review from
2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. Cancer 2008;113:3364-71.
162. McGrory JE, Rock MG, Nascimento AG, et al. Extraskeletal myxoid chondrosarcoma. Clin Orthop Relat Res
2001;382:185-90.
163. Stacchiotti S, Dagrada GP, Sanfilippo R, et al. Anthracycline-based chemotherapy in extraskeletal myxoid
chondrosarcoma: a retrospective study. Clin Sarcoma Res 2013;3:16.
164. Morioka H, Takahashi S, Araki N, et al. Results of subanalysis of a phase 2 study on trabectedin treatment for
extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma. BMC Cancer 2016;16:479.
165. Stacchiotti S, Dagrada GP, Morosi C, et al. Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib.
Clin Sarcoma Res 2012;2:22.
166. Stacchiotti S, Pantaleo MA, Astolfi A, et al. Activity of sunitinib in extraskeletal myxoid chondrosarcoma. Eur
J Cancer 2014;50:1657-64.